Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01182350
Title Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

childhood brain stem glioma

Therapies

Bevacizumab + Temozolomide

Bevacizumab + Erlotinib + Temozolomide

Bevacizumab + Erlotinib

Bevacizumab

Age Groups: child
Covered Countries USA


No variant requirements are available.